Type to search

Pfizer to Acquire Biohaven Pharmaceuticals | Pharmtech Focus
Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment | Pharmtech Focus
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea | Pharmtech Focus